PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma
Clinical trial NCT01585649 · COMPLETED
Trial details
- NCT number
- NCT01585649
- Sponsor
- Merckle GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.